A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects.

Normal cardiovascular development is exquisitely dependent on the correct dosage of the angiogenic growth factor and vascular morphogen vascular endothelial growth factor (VEGF). However, cardiac expression of VEGF is also robustly augmented during hypoxic insults, potentially mediating the well-established teratogenic effects of hypoxia on heart development. We report that during normal heart morphogenesis VEGF is specifically upregulated in the atrioventricular (AV) field of the heart tube soon after the onset of endocardial cushion formation (i.e. the endocardium-derived structures that build the heart septa and valves). To model hypoxia-dependent induction of VEGF in vivo, we conditionally induced VEGF expression in the myocardium using a tetracycline-regulated transgenic system. Premature induction of myocardial VEGF in E9.5 embryos to levels comparable with those induced by hypoxia prevented formation of endocardial cushions. When added to explanted embryonic AV tissue, VEGF fully inhibited endocardial-to-mesenchymal transformation. Transformation was also abrogated in AV explants subjected to experimental hypoxia but fully restored in the presence of an inhibitory soluble VEGF receptor 1 chimeric protein. Together, these results suggest a novel developmental role for VEGF as a negative regulator of endocardial-to-mesenchymal transformation that underlies the formation of endocardial cushions. Moreover, ischemia-induced VEGF may be the molecular link between hypoxia and congenital defects in heart septation.

[1]  A. Nagy,et al.  Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. , 2000, Development.

[2]  Napoleone Ferrara,et al.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.

[3]  D. L. Weeks,et al.  TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. , 1999, Developmental biology.

[4]  Raymond B. Runyan,et al.  Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. , 1999, Science.

[5]  J. Redondo,et al.  Vascular Endothelial Growth Factor Activates Nuclear Factor of Activated T Cells in Human Endothelial Cells: a Role for Tissue Factor Gene Expression , 1999, Molecular and Cellular Biology.

[6]  R. Markwald,et al.  Mechanisms of Segmentation, Septation, and Remodeling of the Tubular Heart , 1999 .

[7]  J A Epstein,et al.  Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. , 1998, Development.

[8]  B. Keyt,et al.  Homologous Up-regulation of KDR/Flk-1 Receptor Expression by Vascular Endothelial Growth Factor in Vitro * , 1998, The Journal of Biological Chemistry.

[9]  Tak W. Mak,et al.  Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum , 1998, Nature.

[10]  G. Nolan.  Cardiac development: Transcription and the broken heart , 1998, Nature.

[11]  Michael J. Grusby,et al.  The transcription factor NF-ATc is essential for cardiac valve formation , 1998, Nature.

[12]  G. Martiny-Baron,et al.  Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. , 1997, Cancer research.

[13]  Y. Dor,et al.  Ischemia-driven angiogenesis. , 1997, Trends in cardiovascular medicine.

[14]  M. Feucht,et al.  VEGF induces cardiovascular malformation and embryonic lethality. , 1997, The American journal of pathology.

[15]  K. Plate,et al.  Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. , 1997, Cancer research.

[16]  E. Keshet,et al.  Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Fishman,et al.  Conditional transgene expression in the heart. , 1996, Circulation research.

[18]  D. Srivastava,et al.  Molecular Pathways Controlling Heart Development , 1996, Science.

[19]  Lieve Moons,et al.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.

[20]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[21]  W. Risau,et al.  Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. , 1995, Developmental biology.

[22]  C. Little,et al.  Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R R Markwald,et al.  Molecular regulation of atrioventricular valvuloseptal morphogenesis. , 1995, Circulation research.

[24]  M. Goldberg,et al.  Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*) , 1995, The Journal of Biological Chemistry.

[25]  E. Keshet,et al.  Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[26]  T. Sasaki,et al.  Extracellular matrix protein fibulin-2 is expressed in the embryonic endocardial cushion tissue and is a prominent component of valves in adult heart. , 1995, Developmental biology.

[27]  G. Fishman,et al.  Regulated expression of foreign genes in vivo after germline transfer. , 1994, The Journal of clinical investigation.

[28]  E. Keshet,et al.  Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. , 1994, Cardiovascular research.

[29]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Lyons,et al.  Developmental regulation of myosin gene expression in mouse cardiac muscle , 1990, The Journal of cell biology.

[31]  J. R. Zuberbuhler,et al.  Prevalence of congenital cardiac anomalies at high altitude. , 1988, Journal of the American College of Cardiology.

[32]  Raymond B. Runyan,et al.  Invasion of mesenchyme into three-dimensional collagen gels: a regional and temporal analysis of interaction in embryonic heart tissue. , 1983, Developmental biology.

[33]  R. Markwald,et al.  Migratory behavior of cardiac cushion tissue cells in a collagen-lattice culture system. , 1982, Developmental biology.

[34]  O. Jaffee.  Abnormal Organogenesis in the Cardiovascular System , 1977 .

[35]  O. Jaffee.  The effects of moderate hypoxia and moderate hypoxia plus hypercapnea on cardiac development in chick embryos. , 1974, Teratology.

[36]  T. Clemmer,et al.  Abnormal Development of the Rat Heart During Prenatal Hypoxic Stress.∗ , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[37]  T. Ingalls,et al.  Experimental production of congenital anomalies; timing and degree of anoxia as factors causing fetal deaths and congenital anomalies in the mouse. , 1952, The New England journal of medicine.